Thought Leadership & Other Media

AGC Biologics Solves Capacity Shortages in Cell and Gene Therapy Space

Events Thought Leadership Cell & Gene Therapy AAV vector manufacturing

The cell and gene therapy (C&GT) market is experiencing an explosion of growth with record-breaking financing, major clinical milestones, and commercial progress creating seemingly vast opportunities.  An enormous pipeline of treatments in the market has created seemingly endless possibilities. However, this explosive growth results in one issue set to derail the promise of this sector – manufacturing capacity shortages. 
 
Capacity shortages were a key topic of discussion at the Meeting on the Mesa last week, one of the premier annual C&GT events organized by the Alliance for Regenerative Medicine. At the event, we met with many companies looking for an experienced partner that can help bring their transformative treatments through every phase of approvals, and eventually to patients in need. 
 
Creating new manufacturing capacity requires investments, lead time and technical expertise. It also requires finding the right CDMO with a global footprint, large-scale capacities and resources, and technical expertise in developing and bringing treatments to market. 

AGC Biologics Offers Virtual Tour of Expanded Milan Cell & Gene Therapy Center During European Biotech Week 2021

Events Cell & Gene Therapy Virtual Site Tour

Since 2013, European Biotech Week has been a premier event offering exclusive content, meetings and demonstrations that highlight how biotech can improve our quality of life. 
 
This year, we are excited to partner with European Biotech Week 2021 to open the doors of our expanded state-of-the-art Cell and Gene Therapy Center of Excellence and production facility in Milan, Italy. 
As a global CDMO, we are laser-focused on building the industry’s best cell and gene therapy (C&GT) and biologics development and manufacturing services. 
On October 1st at 11:00 am CET, AGC Biologics is hosting a free virtual tour that showcases our end-to-end capabilities and our new Process Development and Quality Control laboratories. 
 
You don’t want to miss it, sign-up today! 

Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy

Events Thought Leadership Cell & Gene Therapy

Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020. 

Follow Us
Join us on LinkedIn Follow us on Twitter